To compare the functional maps with their corresponding protein structures, we highlighted those critical residues identified from PASTMUS on the surface diagram of three cancer drug targets (PSMB5, PLK1, and HPRT1) (Fig. 6a, d, g). This evidence concerns the gene HPRT1 and cancer.